| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1750-3639.1997.TB01062.X |
| P8608 | Fatcat ID | release_znochlby5bdi3cbtmbqvfwna44 |
| P698 | PubMed publication ID | 9161727 |
| P2093 | author name string | Louis DN | |
| P2860 | cites work | Growth suppression by p16ink4 requires functional retinoblastoma protein | Q24317567 |
| A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 | Q24322196 | ||
| Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations | Q27730815 | ||
| Lessons from hereditary colorectal cancer | Q28131788 | ||
| Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers | Q28251857 | ||
| A cell cycle regulator potentially involved in genesis of many tumor types | Q28251933 | ||
| Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest | Q28270478 | ||
| Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours | Q29618396 | ||
| Clonal expansion of p53 mutant cells is associated with brain tumour progression | Q34233614 | ||
| Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification | Q34350623 | ||
| Cloning of a highly conserved human protein serine-threonine phosphatase gene from the glioma candidate region on chromosome 19q13.3. | Q34385151 | ||
| Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology | Q34435505 | ||
| Mortality from second tumors among long-term survivors of retinoblastoma | Q34729393 | ||
| Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis | Q36079701 | ||
| Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas | Q36553577 | ||
| Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications | Q39495167 | ||
| A tiger behind many doors: multiple genetic pathways to malignant glioma | Q40372189 | ||
| Life, death, and the pursuit of apoptosis. | Q40942974 | ||
| Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme | Q41075821 | ||
| Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition | Q41335802 | ||
| Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. | Q41563742 | ||
| Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis | Q41563751 | ||
| Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours | Q42590778 | ||
| Loss of heterozygosity for 10q loci in human gliomas | Q46637661 | ||
| Chromosome 11p15 deletions in human malignant astrocytomas and primitive neuroectodermal tumors | Q48415494 | ||
| Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. | Q53478421 | ||
| 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers | Q55480673 | ||
| Loss of heterozygosity for distal markers on 22q in human gliomas | Q55483473 | ||
| TP53 Gene Mutations and 17p Deletions in Human Astrocytomas | Q55483973 | ||
| Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. | Q55487073 | ||
| Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 | Q59082348 | ||
| Life (and death) in a malignant tumour | Q59098941 | ||
| P433 | issue | 2 | |
| P921 | main subject | astrocytoma | Q177755 |
| P304 | page(s) | 755-764 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | Brain Pathology | Q4955776 |
| P1476 | title | A molecular genetic model of astrocytoma histopathology | |
| P478 | volume | 7 |
| Q33997839 | "...those left behind." Biology and oncology of invasive glioma cells |
| Q48171207 | A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading |
| Q35764885 | Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas. |
| Q41869473 | Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor |
| Q55475569 | Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features. |
| Q34132978 | Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance. |
| Q55475416 | Analysis of the p300/CBP-Associated Factor (PCAF) gene in astrocytic tumors. |
| Q40835076 | Antisense epidermal growth factor receptor RNA transfection in human malignant glioma cells leads to inhibition of proliferation and induction of differentiation |
| Q41896356 | Beyond Genetics in Glioma Pathways: The Ever-Increasing Crosstalk between Epigenomic and Genomic Events |
| Q48712580 | Biologic tumor behavior in pilocytic astrocytomas |
| Q55474994 | CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas. |
| Q33374444 | Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro |
| Q48862436 | Chromosome 22 tiling-path array-CGH analysis identifies germ-line- and tumor-specific aberrations in patients with glioblastoma multiforme |
| Q55474980 | Comparative genomic hybridization reveals recurrent enhancements on chromosome 20 and in one case combined amplification sites on 15q24q26 and 20p11p12 in glioblastomas. |
| Q55477117 | Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences. |
| Q48321455 | Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases |
| Q34133118 | Defective p53 antiangiogenic signaling in glioblastoma |
| Q55475899 | Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours. |
| Q32001534 | Distinct differences in binding capacity to saccharide epitopes in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas, and glioblastomas |
| Q46131414 | Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation |
| Q40706939 | Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy. |
| Q55467284 | Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome. |
| Q48119227 | Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis |
| Q55476458 | Gap junction intercellular communication in gliomas is inversely related to cell motility. |
| Q38514222 | Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study |
| Q48793195 | Glioblastomas with an oligodendroglial component: a pathological and molecular study |
| Q40637532 | HC gp-39 gene is upregulated in glioblastomas |
| Q48425150 | High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH). |
| Q43054130 | Histology-based expression profiling yields novel prognostic markers in human glioblastoma |
| Q34104795 | Identification of prognostic biomarkers for glioblastomas using protein expression profiling |
| Q34102061 | Impact of single nucleotide polymorphism in IL-4, IL-4R genes and systemic concentration of IL-4 on the incidence of glioma in Iraqi patients |
| Q30444938 | In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms |
| Q40667642 | Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells |
| Q55475713 | Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. |
| Q48144051 | Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype |
| Q48101895 | Loss of chromosome 10 in glioblastoma: relation to proliferation and angiogenesis |
| Q49111534 | Low-level microsatellite instability phenotype in sporadic glioblastoma multiforme |
| Q35104265 | Molecular abnormalities and correlations with tumor response and outcome in glioma patients |
| Q35918862 | Molecular analysis of pediatric brain tumors |
| Q55476987 | Molecular genetic analysis of non-astrocytic gliomas. |
| Q49142255 | Molecular genetics of radiographically defined de novo glioblastoma multiforme |
| Q35799973 | Molecular pathogenesis of pediatric astrocytic tumors |
| Q36619048 | Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas. |
| Q33958407 | Neurocysticercosis and oncogenesis |
| Q40453259 | PAX6 suppresses growth of human glioblastoma cells. |
| Q37640890 | PCNA and Ki-67 labelling indices in pre-irradiated and post-irradiated astrocytomas: a comparative immunohistochemical analysis for evaluation of proliferative activity |
| Q48882899 | Pattern of self-organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model |
| Q35570946 | Polymorphisms associated with asthma are inversely related to glioblastoma multiforme |
| Q55475412 | Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy. |
| Q44177331 | Reduced beta-catenin expression is associated with good prognosis in Astrocytoma |
| Q34514088 | Risk assignment in childhood brain tumors: the emerging role of molecular and biologic classification |
| Q47294523 | Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling |
| Q44117460 | Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes |
| Q34118955 | Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones |
| Q44603942 | TP53 deleted cells in de novo glioblastomas using fluorescence in situ hybridization |
| Q37221647 | Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling |
| Q46160238 | Wnt/beta-catenin/Tcf signaling pathway activation in malignant progression of rat gliomas induced by transplacental N-ethyl-N-nitrosourea exposure |
| Q55478158 | p27/kip1 expression in human astrocytic gliomas. |
Search more.